1. Home
  2. ECBK vs IVA Comparison

ECBK vs IVA Comparison

Compare ECBK & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECBK
  • IVA
  • Stock Information
  • Founded
  • ECBK 1919
  • IVA 2011
  • Country
  • ECBK United States
  • IVA France
  • Employees
  • ECBK N/A
  • IVA N/A
  • Industry
  • ECBK Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECBK Finance
  • IVA Health Care
  • Exchange
  • ECBK Nasdaq
  • IVA Nasdaq
  • Market Cap
  • ECBK 123.1M
  • IVA 117.3M
  • IPO Year
  • ECBK N/A
  • IVA 2020
  • Fundamental
  • Price
  • ECBK $14.49
  • IVA $2.16
  • Analyst Decision
  • ECBK
  • IVA Strong Buy
  • Analyst Count
  • ECBK 0
  • IVA 4
  • Target Price
  • ECBK N/A
  • IVA $13.25
  • AVG Volume (30 Days)
  • ECBK 4.8K
  • IVA 7.3K
  • Earning Date
  • ECBK 10-24-2024
  • IVA 09-25-2024
  • Dividend Yield
  • ECBK N/A
  • IVA N/A
  • EPS Growth
  • ECBK N/A
  • IVA N/A
  • EPS
  • ECBK 0.39
  • IVA N/A
  • Revenue
  • ECBK $24,711,000.00
  • IVA $20,652,523.00
  • Revenue This Year
  • ECBK N/A
  • IVA N/A
  • Revenue Next Year
  • ECBK N/A
  • IVA $361.78
  • P/E Ratio
  • ECBK $37.11
  • IVA N/A
  • Revenue Growth
  • ECBK N/A
  • IVA N/A
  • 52 Week Low
  • ECBK $11.39
  • IVA $1.53
  • 52 Week High
  • ECBK $15.75
  • IVA $4.50
  • Technical
  • Relative Strength Index (RSI)
  • ECBK 49.53
  • IVA 38.30
  • Support Level
  • ECBK $13.06
  • IVA $2.11
  • Resistance Level
  • ECBK $15.00
  • IVA $2.24
  • Average True Range (ATR)
  • ECBK 0.41
  • IVA 0.07
  • MACD
  • ECBK -0.01
  • IVA 0.01
  • Stochastic Oscillator
  • ECBK 67.14
  • IVA 22.07

About ECBK ECB Bancorp Inc.

ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: